During the past decade, East-West Medical Research Institute conducted 65 clinical trials. In the 10-year time frame, 65 clinical trials started and 54 clinical trials were completed, i.e. on average, 83.1% percent of trials that started reached the finish line to date. In the past 5 years, 36 clinical trials started and 38 clinical trials were completed. i.e. 105.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "East-West Medical Research Institute" #1 sponsor was "Pfizer" with 31 trials, followed by "Eli Lilly and Company" with 14 trials sponsored, "BioNTech SE" with 5 trials sponsored, "ModernaTX, Inc." with 5 trials sponsored and "AstraZeneca" with 5 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "East-West Medical Research Institute" #1 collaborator was "Pfizer" with 5 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "East-West Medical Research Institute" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "East-West Medical Research Institute" are "Diabetes Mellitus, Type 2" (8 trials), "COVID-19" (6 trials), "SARS-CoV-2 Infection" (6 trials), "Type 2 Diabetes Mellitus" (6 trials) and "Obesity" (5 trials). Many other conditions were trialed in "East-West Medical Research Institute" in a lesser frequency.

Most popular intervention types in "East-West Medical Research Institute" are "Drug" (56 trials), "Biological" (35 trials), "Other" (14 trials), "Device" (4 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (43 trials), "BNT162b2" (5 trials), "Insulin Degludec" (4 trials), "Tirzepatide" (4 trials) and "mRNA-1345" (4 trials). Other intervention names were less common.

The vast majority of trials in "East-West Medical Research Institute" are 91 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "East-West Medical Research Institute". undefined are not yet recruiting, 6 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 67 completed trials in East-West Medical Research Institute, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in East-West Medical Research Institute, 8 "Phase 1" clinical trials were conducted, 33 "Phase 2" clinical trials and 47 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".